Ronit Juthani
Internal Medicine · Worcester, MANPI 1922786128
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 29.7% of the total.
Across 61 payments — averaging $23.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$420
- AstraZeneca$207
- Bayer$90
- Takeda Pharmaceuticals U.S.A., Inc.$77
- Johnson & Johnson$73
- Fresenius Kabi USA, LLC$71
- plus $478 from 15 others
What the payments were for
- Food & beverage$1,417100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $420 |
| AstraZeneca(2 entities) | 10 | $207 |
| Bayer | 5 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Johnson & Johnson(2 entities) | 2 | $73 |
| Fresenius Kabi USA, LLC | 3 | $71 |
| Novo Nordisk | 3 | $64 |
| E.r. Squibb & Sons, L.L.C. | 3 | $56 |
| Grifols USA, LLC | 2 | $49 |
| GSK | 3 | $46 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Argenx US, Inc. | 1 | $31 |
| Boehringer Ingelheim | 1 | $28 |
| Gilead | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Pfizer | 1 | $21 |
| Alcresta Therapeutics, Inc. | 1 | $19 |
| Amgen | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $14 |
How this compares
$1,417 in reported general payments places this provider in the 85th percentile of 4,983 internal medicine providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 13 | $488 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Worcester
- David SchenkeinBoston$5M
- Alan GarberCambridge$4.9M
- John FallonBoston$1.8M
- Michael MendelsohnBoston$1.6M
- Sandra RichmanBrookline$1.4M
- Gaurav SingalBoston$798K
- Asit ParikhBoston$486K
- Noopur RajeBoston$481K
- Daniel KuritzkesBoston$443K
- Xiuning leBoston$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.